X4 Pharmaceuticals Inc (NASDAQ:XFOR) price on Thursday, July 03, fall -4.55% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.89.
A look at the stock’s price movement, the close in the last trading session was $1.98, moving within a range at $1.85 and $2.028. The beta value (5-Year monthly) was 0.663 while the PE ratio in trailing twelve months stood at 0.84. Turning to its 52-week performance, $26.96 and $1.81 were the 52-week high and 52-week low respectively. Overall, XFOR moved -52.27% over the past month.
X4 Pharmaceuticals Inc’s market cap currently stands at around $10.94 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-01.
Turning to the stock’s technical picture we see that short term indicators suggest on average that XFOR is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend XFOR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
XFOR’s current price about -30.03% and -42.80% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 29.94, while 7-day volatility ratio is 10.32% and 11.22% in the 30-day chart. Further, X4 Pharmaceuticals Inc (XFOR) has a beta value of 0.60. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $5. Looking at the price targets, the low is -58.73% off current price level while to achieve the yearly target high, price needs to move -164.55%. Nonetheless, investors will most likely welcome a -58.73% jump to $3 which is the analysts’ median price.
If we refocus on X4 Pharmaceuticals Inc (NASDAQ:XFOR), historical trading data shows that trading volumes averaged 0.46 over the past 10 days and 255.58K over the past 3 months. The company’s latest data on shares outstanding shows there are 5.79 million shares.
The 33.61% of X4 Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 29.17% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.48 million on 2025-06-13, giving us a short ratio of 1.64. The data shows that as of 2025-06-13 short interest in X4 Pharmaceuticals Inc (XFOR) stood at 850.0 of shares outstanding, with shares short rising to 0.31 million registered in 2025-05-15. Current price change has pushed the stock -89.31% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the XFOR stock continues to rise going into the next quarter.
